Smith & Nephew SNATS, Inc. Plans Dividend of $0.31 (NYSE:SNN)

Smith & Nephew SNATS, Inc. (NYSE:SNN) declared a dividend on Tuesday, August 4th. Shareholders of record on Friday, October 2nd will be given a dividend of 0.312 per share by the medical equipment provider on Friday, November 6th. This represents a dividend yield of 205.0%. The ex-dividend date is Friday, October 2nd.

Smith & Nephew SNATS has a payout ratio of 42.5% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Smith & Nephew SNATS to earn $2.48 per share next year, which means the company should continue to be able to cover its $0.93 annual dividend with an expected future payout ratio of 37.5%.

Smith & Nephew SNATS Trading Down 1.5%

Shares of SNN stock traded down $0.45 during trading hours on Wednesday, hitting $29.99. 296,841 shares of the company were exchanged, compared to its average volume of 1,188,780. The company has a 50 day simple moving average of $30.45 and a two-hundred day simple moving average of $32.18. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.25 and a current ratio of 2.57. Smith & Nephew SNATS has a fifty-two week low of $28.56 and a fifty-two week high of $38.79.

Institutional Trading of Smith & Nephew SNATS

Several hedge funds have recently bought and sold shares of SNN. Parallel Advisors LLC raised its holdings in Smith & Nephew SNATS by 20.0% during the first quarter. Parallel Advisors LLC now owns 2,322 shares of the medical equipment provider’s stock worth $74,000 after buying an additional 387 shares during the last quarter. Sunbelt Securities Inc. bought a new position in shares of Smith & Nephew SNATS in the first quarter valued at $92,000. Parvin Asset Management LLC grew its holdings in shares of Smith & Nephew SNATS by 8.5% during the first quarter. Parvin Asset Management LLC now owns 36,944 shares of the medical equipment provider’s stock valued at $1,174,000 after buying an additional 2,894 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in shares of Smith & Nephew SNATS by 33.2% during the first quarter. EverSource Wealth Advisors LLC now owns 6,427 shares of the medical equipment provider’s stock valued at $204,000 after buying an additional 1,602 shares during the last quarter. Finally, Royal Bank of Canada increased its position in shares of Smith & Nephew SNATS by 6.7% during the first quarter. Royal Bank of Canada now owns 337,118 shares of the medical equipment provider’s stock worth $10,713,000 after acquiring an additional 21,039 shares in the last quarter. Institutional investors and hedge funds own 25.64% of the company’s stock.

About Smith & Nephew SNATS

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.